Kappa Opioid Receptors Are the Strongest Regulators of Pregnancy Hormone hCG in Placental Tissue
All three opioid receptor types stimulated hCG release from placental tissue, but kappa receptors were far more potent than mu or delta.
Quick Facts
What This Study Found
Order of potency for hCG release: kappa >>> mu > delta. All three produced bell-shaped dose-response curves. Kappa dominance confirmed.
Key Numbers
How They Did This
Term human trophoblast tissue was cultured in vitro with opioid agonists selective for kappa (dynorphin 1-13), mu (DAMGO), and delta (DPDPE) receptors. hCG release was measured.
Why This Research Matters
This confirms the placenta uses kappa opioid signaling to regulate a critical pregnancy hormone. Opioid drugs during pregnancy could directly alter hCG levels, which is essential for maintaining pregnancy.
The Bigger Picture
hCG is essential for maintaining pregnancy. This study shows the placenta's opioid system — primarily through kappa receptors — directly controls hCG release, raising concerns about how opioid drugs might affect pregnancy outcomes.
What This Study Doesn't Tell Us
In vitro study using isolated placental tissue. May not reflect the complexity of intact placental function. Only hCG measured.
Questions This Raises
- ?Could opioid drug use during pregnancy alter hCG levels enough to affect pregnancy viability?
- ?Why do all three receptor types produce bell-shaped dose-response curves?
Trust & Context
- Key Stat:
- Kappa >>> mu > delta Kappa opioid receptors were dramatically more potent at stimulating hCG release from human placental tissue
- Evidence Grade:
- Preliminary — an in vitro study on isolated term placental tissue. Results are clear but limited to a lab setting without the complexity of whole-body pregnancy physiology.
- Study Age:
- Published in 1992 (34 years ago). Builds on earlier work identifying kappa receptors as the dominant opioid type in placental tissue.
- Original Title:
- Selectivity and potency of opioid peptides in regulating human chorionic gonadotropin release from term trophoblast tissue.
- Published In:
- Peptides, 13(5), 897-903 (1992)
- Authors:
- Cemerikic, B(2), Schabbing, R, Ahmed, M S(2)
- Database ID:
- RPEP-00226
Evidence Hierarchy
Frequently Asked Questions
What is hCG and why does it matter?
Human chorionic gonadotropin (hCG) is a hormone produced by the placenta that maintains pregnancy. Without adequate hCG, pregnancy cannot continue. This study shows opioid receptors directly control its release.
What does "bell-shaped dose response" mean?
It means that moderate amounts of the opioid peptide increased hCG release, but very high amounts actually reduced the effect. This is common with biological systems and suggests there's an optimal level of stimulation.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00226APA
Cemerikic, B; Schabbing, R; Ahmed, M S. (1992). Selectivity and potency of opioid peptides in regulating human chorionic gonadotropin release from term trophoblast tissue.. Peptides, 13(5), 897-903.
MLA
Cemerikic, B, et al. "Selectivity and potency of opioid peptides in regulating human chorionic gonadotropin release from term trophoblast tissue.." Peptides, 1992.
RethinkPeptides
RethinkPeptides Research Database. "Selectivity and potency of opioid peptides in regulating hum..." RPEP-00226. Retrieved from https://rethinkpeptides.com/research/cemerikic-1992-selectivity-and-potency-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.